WorksheetsPRCC_3MT-P2
Total questions: 170
Worksheet time: 1hrs 25mins
Name
Class
Date
1.
Low sensitivity, more specific to albumin
a)
HABA
b)
Coomasie brilliant blue
2.
Used to measure protein in cerebrospinal fluid
a)
HABA
b)
Coomasie brilliant blue
3.
severe dehydration
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
4.
prolonged tourniquet application
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
5.
Artifactual or artificial hyperalbuminemia
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
6.
Chronic liver disease
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
7.
Malabsorption
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
8.
Malnutrition
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
9.
Nephrotic syndrome
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
10.
Massive burns
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
11.
Exfoliative dermatitis
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
12.
Protein-losing enteropathy
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
13.
Orthosthatic proteinuria
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
14.
Malignancy such as Multiple myeloma
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
15.
Hyperthyroidism
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
16.
Thyrotoxicosis
a)
Increased Albumin
b)
Decreased albumin, low synthesis
c)
Decreased albumin, increased loss
d)
Decreased albumin, increased catabolism
17.
Major inhibitor of protease activity
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
18.
Highest concentration of the plasma proteolytic inhibitors
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
19.
Neutralizes trypsin-like enzymes (elastase)
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
20.
Deficient: pulmonary emphysema
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
21.
Defective: Liver cirrhosis
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
22.
Synthesize in the developing embryo and fetus and decrease after birth
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
23.
Sample: maternal serum
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
24.
Binds estradiol
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
25.
Tumor marker of hepatic and gonadal cancer - serum sample
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
26.
Neural tube defect and down syndrome and Edward syndrome (Trisomy 18)
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
27.
Increased in maternal serym
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
28.
Associated with atresia of the GIT, fetal distress, ataxia telangiectasia, tyrosinosis, HDN, twins
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
29.
A major plasma glycoprotein (45% CHO), is negatively charged even in acid solutions.
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
30.
greatest affinity for progesterone
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
31.
Serine protease inhibitors
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
32.
Has important role in inflammation and carcinogenesis
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
33.
Acute phase reactant that inhibits: Cathepsin G, Pancreatic elastase, mast cell chymase, and chymotrypsin
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
34.
Binds and inactivates prostate specific antigen (PSA) - the major form of PSA found in human sera.
a)
Alpha 1 antitrypsin
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
35.
Major carrier of Vitamin D
a)
Gc-globulin (Group-specific component)
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
36.
Important for bone formation
a)
Gc-globulin (Group-specific component)
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
37.
Carries fatty acid and endotoxin
a)
Gc-globulin (Group-specific component)
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
38.
Binds actin
a)
Gc-globulin (Group-specific component)
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
39.
Co-chemotactic factor
a)
Gc-globulin (Group-specific component)
b)
Alpha 1-fetoprotein
c)
Alpha 1-acid glycoprotein / orosomucoid (AAG)
d)
Alpha 1- antichymotrypsin
e)
Inter-alpha-Trypsin inhibitor
40.
Gc-globulin is a major carrier of...
a)
Vitamin A
b)
Vitamin B
c)
VItamin D
d)
Vitamin B12
41.
A1-acid glycoprotein has greatest affinity for...
a)
Estrogen
b)
Progesterone
c)
Androgen
d)
Testosterone
42.
High AFP
a)
Neural tube defect
b)
Down syndrome
c)
Edward syndrome
43.
Anencephaly
a)
High AFP
b)
Low AFP
44.
Spina bifida
a)
High AFP
b)
Low AFP
45.
Neural tube defect
a)
High AFP
b)
Low AFP
46.
Down syndrome
a)
High AFP
b)
Low AFP
47.
Edward syndrome (Trisomy 18)
a)
High AFP
b)
Low AFP
48.
Low AFP
a)
Neural tube defect
b)
Down syndrome
c)
Edward syndrome
49.
Pulmonary emphysema in A1 antitrypsin
a)
Deficient
b)
Defective
50.
Liver cirrhosis in A1 antitrypsin
a)
Deficient
b)
Defective
51.
Binds hemoglobin by its alpha chain
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
52.
Intravascular hemolysis = low
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
53.
Purpose include:
1. To protect the kidneys
2. To protect iron from kidneys or to conserve iron
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
54.
A copper binding alpha-2 glycoprotein that has enzymatic activities
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
55.
Imparts blue color to protein
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
56.
Decreased in Wilson's disease, malnutrition, malabsorption, nephrotic syndrome, and Menkes Kinky hair syndrome.
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
57.
Associated with Kayser Fleischer Ring
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
58.
Inhibits proteases such as trypsin, thrombin, kallikrein, and plasmin
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
59.
LARGEST major nonimmunoglobulin protein in plasma
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
60.
10x in nephrosis
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
61.
Inhibits proteases such as trypsin, thrombin, kallikrein, and plasmin
a)
Haptoglobin
b)
Ceruloplasmin
c)
Alpha-2 macroglobulin
62.
Ceruloplasmin imparts what color to protein?
a)
Blue
b)
Brown
c)
Red
d)
Green
e)
Black
63.
Intravascular hemolysis in Haptoglobin
a)
Low
b)
High
64.
Spike in a2 region
a)
Iron deficiency anemia
b)
Waldenstrom macroglobulinemia
c)
Nephrotic syndrome
d)
DIC
65.
Good prognosis
a)
Normal levels of fibrinogen
b)
High levels of fibrinogen
66.
Bad prognosis
a)
Normal levels of fibrinogen
b)
High levels of fibrinogen
67.
Binds heme
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
68.
Associated with conversion of iron as well
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
69.
Helps in the diagnosis of early hemolysis
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
70.
Also known as siderophilin
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
71.
Iron-loving
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
72.
Major component of beta globulin fraction
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
73.
Negative acute phase reactant
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
74.
Transports iron
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
75.
Associated with IDA and hemochromatosis (bronze skin)
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
76.
Most abundant of the coagulation factors
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
77.
Increased in cases of inflammation
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
78.
It is considered as a marker for long-term prognosis of cardiovascular disease
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
79.
DIC-low fibrinogen, high D-dimer
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
80.
Participates in immune response via cell lysis and inflammation
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
81.
Increased in inflammatory states
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
82.
Decreased in autoimmune disease, hemolytic anemia, malnutrition, and DIC
a)
Hemopexin
b)
Transferrin
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
83.
Light chain component of the MHC
a)
Hemopexin
b)
Lipoprotein
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
84.
Increase: inflammatory diseases (such as RA, SLE), HIV in patients, Multiple myeloma, and diabetes mellitus
a)
Hemopexin
b)
Lipoprotein
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
85.
Folds into a B-sheet confugration after dialysis - dialysis associated amyloidosis
a)
Hemopexin
b)
Lipoprotein
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
86.
Already discussed in previous chapter asjhSHJDKH
a)
Hemopexin
b)
Lipoprotein
c)
Fibrinogen
d)
Complement
e)
Beta2-Microglobulin
87.
Complement in autoimmune disease
a)
Increased
b)
Decreased
88.
Complement in Hemolytic anemia
a)
Increased
b)
Decreased
89.
Complement in malnutrition
a)
Increased
b)
Decreased
90.
Complement in DIC
a)
Increased
b)
Decreased
91.
Complement in Inflammatory states
a)
Increased
b)
Decreased
92.
Disseminated intravascular coagulation
a)
Low fibrinogen, high D-dimer
b)
High fibrinogen, low D-dimer
c)
Low fibrinogen, low D-dimer
d)
High fibrinogen, high D-dimer
93.
Serum Iron (Fe): Decreased
Ferritin: Decreased
Transferrin: Increased
a)
Iron deficiency anemia (IDA)
b)
Hemochromatosis
c)
Anemia of Chronic disease (ACD) / ACL
d)
Malnutrition
94.
Serum Iron (Fe): Increased
Ferritin: Increased
Transferrin: Decreased
a)
Iron deficiency anemia (IDA)
b)
Hemochromatosis
c)
Anemia of Chronic disease (ACD) / ACL
d)
Malnutrition
95.
Serum Iron (Fe): Decreased
Ferritin: Increased
Transferrin: Decreased
a)
Iron deficiency anemia (IDA)
b)
Hemochromatosis
c)
Anemia of Chronic disease (ACD) / ACL
d)
Malnutrition
96.
Serum Iron (Fe): Decreased
Ferritin: Decreased
Transferrin: Decreased
a)
Iron deficiency anemia (IDA)
b)
Hemochromatosis
c)
Anemia of Chronic disease (ACD) / ACL
d)
Malnutrition
97.
Spike in Beta-region
a)
Iron deficiency anemia (IDA)
b)
Hemochromatosis
c)
Anemia of Chronic disease (ACD) / ACL
d)
Malnutrition
98.
Binds to the C-polysaccharide of the pneumococcus
a)
C-reactive protein
b)
Immunoglobulins
99.
Parameter of acute inflammation
a)
C-reactive protein
b)
Immunoglobulins
100.
Early warning test to persons at risk of coronary artery disease
a)
C-reactive protein
b)
Immunoglobulins
101.
Synthesis is via plasma B cells
a)
C-reactive protein
b)
Immunoglobulins
102.
Primary response antibody
a)
IgM
b)
IgG
c)
IgA
d)
IgE
103.
Indicator of recent infection
a)
IgM
b)
IgG
c)
IgA
d)
IgE
104.
Room temperature or 4 degree Celsius reacting type of antibody.
a)
IgM
b)
IgG
c)
IgA
d)
IgE
105.
Associated and increased in cases of Waldenstrom macroglobulinemia
a)
IgM
b)
IgG
c)
IgA
d)
IgE
106.
Most predominant antibody in plasma and lymph
a)
IgM
b)
IgG
c)
IgA
d)
IgE
107.
Known as anamnestic response antibody; involved in secondary response
a)
IgM
b)
IgG
c)
IgA
d)
IgE
108.
Body temp reacting (37 degree Celsius)
a)
IgM
b)
IgG
c)
IgA
d)
IgE
109.
Found in secretions and mucosal area
a)
IgM
b)
IgG
c)
IgA
d)
IgE
110.
Involved in type 1 hypersensitivity
a)
IgM
b)
IgG
c)
IgA
d)
IgE
111.
Associated with Systemic anaphylaxis
a)
IgM
b)
IgG
c)
IgA
d)
IgE
112.
Associated with parasitic infection
a)
IgM
b)
IgG
c)
IgA
d)
IgE
113.
Most heat labile antibody
a)
IgM
b)
IgG
c)
IgA
d)
IgE
114.
Location: B cell surface
a)
Monoclonal gammopathy
b)
IgD
c)
IgA
d)
IgE
115.
Function: B cell maturation
a)
Monoclonal gammopathy
b)
IgD
c)
IgA
d)
IgE
116.
Is increased in liver disorders, infections, and connective tissue disorders
a)
Monoclonal gammopathy
b)
IgD
c)
IgA
d)
IgE
117.
Characterized by increased in one of the immunoglobulins
a)
Monoclonal gammopathy
b)
IgD
c)
IgA
d)
IgE
118.
Example: multiple myeloma
a)
Monoclonal gammopathy
b)
IgD
c)
IgA
d)
IgE
119.
Increase in IgG, IgA, or IgM (seldom IgD or IgE)
a)
Monoclonal gammopathy
b)
IgD
c)
IgA
d)
IgE
120.
Best in crossing the placenta
a)
IgG 1
b)
IgG 2
c)
IgG 3
d)
IgG 4
121.
Least in crossing the placenta
a)
IgG 1
b)
IgG 2
c)
IgG 3
d)
IgG 4
122.
Best in fixing the complement
a)
IgG 1
b)
IgG 2
c)
IgG 3
d)
IgG 4
123.
Least in fixing the complement
a)
IgG 1
b)
IgG 2
c)
IgG 3
d)
IgG 4
124.
Reference value of Albumin/globulin ratio
a)
1.3 to 3:1
b)
2.3 to 3.5 g/dL
c)
10 g/L
125.
Reference value of Globulins = Total protein - Albumin
a)
1.3 to 3:1
b)
2.3 to 3.5 g/dL
c)
10 g/L
126.
Reference value of CF
Globulins = Total protein - Albumin
a)
1.3 to 3:1
b)
2.3 to 3.5 g/dL
c)
10 g/L
127.
Reference value of Albumin/globulin ratio
a)
1.3 to 3:1
b)
2.3 to 3.5 g/dL
c)
10 g/L
128.
Inverted AG Ratio
a)
Globulin > Albumin
b)
Albumin > Globulin
129.
Consists of a1, a2, B, and y fractions
a)
Globulin
b)
Albumin
130.
Dehydration
a)
High A/G ratio
b)
Low A/G ratio
131.
Prolonged tourniquet
a)
High A/G ratio
b)
Low A/G ratio
132.
Newborn
a)
High A/G ratio
b)
Low A/G ratio
133.
Agammaglobulinemia
a)
High A/G ratio
b)
Low A/G ratio
134.
Hypogammaglobulinemia
a)
High A/G ratio
b)
Low A/G ratio
135.
Immunodeficiency
a)
High A/G ratio
b)
Low A/G ratio
136.
Dehydration
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
137.
Prolonged tourniquet
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
138.
Newborn
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
139.
Agammaglobulinemia
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
140.
Hypogammaglobulinemia
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
141.
Immunodeficiency
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
142.
Decreased production, increased loss
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
143.
Multiple myeloma
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
144.
Inflammation
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
145.
Infection
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
146.
Chronic liver disease
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
147.
Malabsorption
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
148.
Nephrotic syndrome
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
149.
Massive burns and exfoliative dermatitis
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
150.
Protein-losing enteropathy
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
151.
Orthosthatic proteinuria
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
152.
Malignancy - multiple myeloma
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
153.
Thyrotoxicosis
a)
Increased albumin with normal globulin
b)
Normal albumin with low globulin
c)
Low albumin with normal globulin
d)
Increased globulins without increase in albumin
154.
antitrypsin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
155.
fetoprotein
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
156.
acid glycoprotein
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
157.
antichymotrypsin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
158.
inter-a-trypsin inhibitor
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
159.
gc-globulin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
160.
haptoglobin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
161.
ceruloplasmin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
162.
macroglobulin AMG
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
163.
hemopexin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
164.
transferrin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
165.
fibrinogen
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
166.
complement
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
167.
b2 microglobulin
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
168.
lipoprotein
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
169.
C-reactive protein
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
170.
Immunoglobulins
a)
Alpha 1 region
b)
Alpha 2 region
c)
Beta region
d)
Gamma region
100 %
